157774-30-6Relevant articles and documents
Treatment of obesity
-
, (2008/06/13)
A method for the treatment of obesity in an animal such as a human, comprises administering to the animal an effective amount of a peptide which comprises an analogue of the carboxyl-terminal sequence of a growth hormone, particularly an analogue of the carboxyl-terminal sequence of human growth hormone containing amino acid residues 177-191. A pharmaceutical composition for use in the treatment of obesity is also disclosed.
PEPTIDES HAVING BRADYKININ ANTAGONIST ACTION
-
, (2008/06/13)
-
APPLICATION OF THE NG-(2,2,5,7,8-PENTAMETHYLCHROMAN-6-SULPHONYL) DERIVATIVE OF FMOC-ARGININE TO PEPTIDE SYNTHESIS
Green, J.,Ogunjobi, O. M.,Ramage, R.,Stewart, A. S. J.
, p. 4341 - 4344 (2007/10/02)
The trifluoroacetic acid labile pentamethylchromanylsulphonyl protecting group for the guanidino group of arginine has been used in conjunction with the base-labile Fmoc Nα protecting group for the synthesis of arginine-containing peptides.